No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Wells Fargo Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $85
Insmed's Promising Growth: Buy Rating Backed by Strong Performance and Strategic Advancements
TD Cowen Maintains Insmed(INSM.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Insmed (INSM)
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Insmed Issues Preliminary Revenue Results, Guidance for Arikayce